Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Woolley

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Current Medical Research and Opinion|January 26, 2018
The prevalence of hyperkalemia in the United StatesKeith A Betts, J Michael Woolley, Fan Mu, et al.
Kidney International Reports|May 5, 2018
The Cost of Hyperkalemia in the United StatesKeith A Betts, J Michael Woolley, Fan Mu, et al.
The Journal of Rheumatology|April 17, 2010
Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritisPhilip J Mease, J Michael Woolley, Amitabh Singh, et al.
Managed Care Interface|May 13, 2006
Clinical and economic burden of psoriasisElisabeth Hazard, Spencer B Cherry, Deepa Lalla, et al.
Journal of the American Academy of Dermatology|October 26, 2005
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trialSteven R Feldman, Alexa Boer Kimball, Gerald G Krueger, et al.
The Journal of Rheumatology|September 3, 2011
Minimally important difference of Health Assessment Questionnaire in psoriatic arthritis: relating thresholds of improvement in functional ability to patient-rated importance and satisfactionPhilip J Mease, J Michael Woolley, Bojena Bitman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 4, 2015
Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalationPatrick W Sullivan, Jonathan D Campbell, Vahram H Ghushchyan, et al.
Current Medical Research and Opinion|May 28, 2020
Prevalence and economic burden of hyperkalemia in the United States Medicare populationFan Mu, Keith A Betts, J Michael Woolley, et al.
Kidney International Reports|August 11, 2020
Postdischarge Health Care Costs and Readmission in Patients With Hyperkalemia-Related HospitalizationsKeith A Betts, J Michael Woolley, Fan Mu, et al.
Molecular Biology of the Cell|July 14, 2017
Actin cytoskeleton-dependent regulation of corticotropin-releasing factor receptor heteromersBurcu Hasdemir, Shilpi Mahajan, Juan Oses-Prieto, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Current Medical Research and Opinion|January 26, 2018
The prevalence of hyperkalemia in the United StatesKeith A Betts, J Michael Woolley, Fan Mu, et al.
Kidney International Reports|May 5, 2018
The Cost of Hyperkalemia in the United StatesKeith A Betts, J Michael Woolley, Fan Mu, et al.
The Journal of Rheumatology|April 17, 2010
Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritisPhilip J Mease, J Michael Woolley, Amitabh Singh, et al.
Managed Care Interface|May 13, 2006
Clinical and economic burden of psoriasisElisabeth Hazard, Spencer B Cherry, Deepa Lalla, et al.
Journal of the American Academy of Dermatology|October 26, 2005
Etanercept improves the health-related quality of life of patients with psoriasis: results of a phase III randomized clinical trialSteven R Feldman, Alexa Boer Kimball, Gerald G Krueger, et al.
The Journal of Rheumatology|September 3, 2011
Minimally important difference of Health Assessment Questionnaire in psoriatic arthritis: relating thresholds of improvement in functional ability to patient-rated importance and satisfactionPhilip J Mease, J Michael Woolley, Bojena Bitman, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 4, 2015
Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalationPatrick W Sullivan, Jonathan D Campbell, Vahram H Ghushchyan, et al.
Current Medical Research and Opinion|May 28, 2020
Prevalence and economic burden of hyperkalemia in the United States Medicare populationFan Mu, Keith A Betts, J Michael Woolley, et al.
Kidney International Reports|August 11, 2020
Postdischarge Health Care Costs and Readmission in Patients With Hyperkalemia-Related HospitalizationsKeith A Betts, J Michael Woolley, Fan Mu, et al.
Molecular Biology of the Cell|July 14, 2017
Actin cytoskeleton-dependent regulation of corticotropin-releasing factor receptor heteromersBurcu Hasdemir, Shilpi Mahajan, Juan Oses-Prieto, et al.
Pageof 4